Antihypertensive medication use in the department of veterans affairs: A national analysis of prescribing patterns from 2000 to 2002

American Journal of Hypertension

Volumn 17, Issue 12, 2004, Pages 1095-1099

  Lopez, Julio ^a,b,c   Meier, Joy ^a,c   Cunningham, Fran ^d   Siegel, David ^a,e,f  

^a Medical Service and Pharmacy Service   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

^d Pharm Benefits Mgmt Strat H   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

guidelines; health care costs; Hypertension; medication use

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; FOSINOPRIL; HYDROCHLOROTHIAZIDE; LISINOPRIL; METOPROLOL; NIFEDIPINE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; DRUG UTILIZATION; GEOGRAPHIC DISTRIBUTION; GOVERNMENT; HYPERTENSION; PHARMACY; PRIORITY JOURNAL; SOLDIER;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DRUG COSTS; HUMANS; HYPERTENSION; PRESCRIPTIONS, DRUG; RECEPTORS, ANGIOTENSIN; SODIUM CHLORIDE SYMPORTER INHIBITORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 11144252276     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.07.015     Document Type: Article

References (25)

1. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension Final results of the Systolic Hypertension in the Elderly Program J Am Med Assoc 265 1991 3255 3264
2. Veterans Administration Cooperative Study Group on Antihypertensive Agents Effect of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg J Am Med Assoc 213 1970 1143 1152
3. M. Wolz, J. Cutler, E.J. Roccella, F. Rohde, T. Thom, V. Burt Statement from the National High Blood Pressure Education Program prevalence of hypertension Am J Hypertens 13 2000 103 104
4. J. Meir, J. Lopez, D. Siegel Prevalence and treatment of hypertension complicated by comorbid conditions J Clin Hypertens 1 1999 209 211
5. Department of Veterans Affairs: Medical Advisory Panel: Pharmacologic management of hypertension. Department of Veterans Affairs, Washington DC, December 1996, publication no. 96-0003.
6. D. Siegel, J. Lopez, J. Meier, M.K. Goldstein, S. Lee, B.J. Brazill, M.S. Matalka Academic detailing to improve antihypertensive prescribing patterns Am J Hypertens 16 2003 508 511
7. A.K. Jha, J.B. Perlin, K.W. Kizer, R.A. Dudley Effect of the transformation of the Veterans Affairs Health Care System on the quality of care N Engl J Med 348 2003 2218 2227
8. D. Siegel, J. Lopez Trends in antihypertensive drug use in the United States are JNC-V recommendations being followed? J Am Med Assoc 278 1997 1945 1948
9. T.A. Manolio, J.A. Cutler, C.D. Furberg, B.M. Psaty, P.K. Whelton, W.B. Applegate Trends in pharmacologic management of hypertension in the United States Arch Intern Med 155 1995 829 837
10. D. Siegel, J. Lopez, J. Meier Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996 Am J Hypertens 11 1998 1271 1278
11. D. Siegel, J. Lopez, J. Meier, F. Cunningham Changes in the pharmacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999 decreased use of calcium antagonists and increased use of β-blockers and thiazide diuretics Am J Hypertens 14 2001 957 962
12. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Arch Intern Med 157 1997 2413 2446
13. R.O. Estacio, B.W. Jeffers, W.R. Hiatt, S.L. Biggestaff, N. Gifford, R.W. Schrier The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependent diabetes and hypertension N Engl J Med 338 1998 645 652
14. M. Pahor, J.M. Guralnik, C.D. Furberg, P. Carbonin, R.J. Havlik Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old Lancet 347 1996 1061 1065
15. M. Pahor, J.M. Guralnik, M.E. Salive, M. Corti, P. Carbonin, R.J. Havlik Do calcium channel blockers increase the risk of cancer? Am J Hypertens 9 1996 695 699
16. C. Bourgalt, B. Rainville, S. Suissa Antihypertensive drug therapy in Saskatchewan patterns of use and determinants in hypertension Arch Intern Med 161 2001 1873 1879
17. T. Walley, A.K. Duggan, A.R. Haycox, C.J. Niziol Treatment for newly diagnosed hypertension patterns of prescribing and antihypertensive effectiveness in the UK J R Soc Med 96 2003 525 531
18. C.R. Nelson, D.A. Knapp Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians Hypertension 36 2000 600 603
19. SL. Clause, R.A. Hamilton Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines Ann Pharmacother 36 2002 1505 1511
20. R.S. Stafford, D. Blumenthal, R.C. Pasternak Variations in cholesterol management practices of U.S. physicians J Am Coll Cardiol 29 1997 139 146
21. R.S. Stafford, D. Saglam, D. Blumenthal National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure Arch Intern Med 157 1997 2460 2464
22. R.P. Patel, S.D. Taylor Factors affecting medication adherence in hypertensive patients Ann Pharmacother 36 2002 40 45
23. M. Monane, R.L. Bohn, J.H. Gurwitz, R.J. Glynn, R. Levin, J. Avorn The effects of initial drug choice and comorbidity on antihypertensive therapy compliance Am J Hypertens 10 1997 697 704
24. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
25. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr, E.J. Roccella National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure National High Blood Pressure Education Program Coordinating The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure J Am Med Assoc 289 2003 2560 2572